Use of Freund's Complete Adjuvant (FCA) in inflammatory pain models: Consequences on the metabolism and pharmacokinetics of the non-peptidic delta receptor agonist SNC80 in the rat

References

• Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC, Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. Journal of Pharmacology and Experimental Therapeutics 1995; 273: 359–366
   PubMed Web of Science ®Google Scholar
• Broccardo M, Improta G, Tabacco A. Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse. European Journal of Pharmacology 1998; 342: 247–251
   PubMedGoogle Scholar
• Cahill CM, Morinville A, Hoffert C, O’Donnell D, Beaudet A. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: Implications for pain control. Pain 2003; 101: 199–208
   PubMed Web of Science ®Google Scholar
• Calderon SN, Coop A. SNC 80 and related delta opioid agonists. Current Pharmaceutical Design 2004; 10: 733–742
   PubMedGoogle Scholar
• Cao CQ, Hong Y, Dray A, Perkins M. Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat. European Journal of Pharmacology 2001; 418: 79–87
   PubMedGoogle Scholar
• Ciba-Geigy. Composition of blood-plasma proteins. Geigy scientific tables, C Lentner. Ciba-Geigy, New Jersey 1984
   Google Scholar
• Delp MD, Evans MV, Duan C. Effects of aging on cardiac output, regional blood flow, and body composition in Fischer-344 rats. Journal of Applied Physiology 1998; 85: 1813–1822
   PubMed Web of Science ®Google Scholar
• Fraser GL, Gaudreau GA, Clarke PB, Menard DP, Perkins MN. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation. British Journal of Pharmacology 2000; 129: 1668–1672
   PubMed Web of Science ®Google Scholar
• Gallantine EL, Meert TF. A comparison of the antinociceptive and adverse effects of the -opioid agonist morphine and the -opioid agonist SNC80. Basic and Clinical Pharmacology and Toxicology 2005; 97: 39–51
   PubMedGoogle Scholar
• Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment, pharmacokinetics. Marcel-Dekker, New York 1982
   Google Scholar
• Houston JB, Carlile DJ. Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metabolism Reviews 1997; 29: 891–922
   PubMed Web of Science ®Google Scholar
• Israili ZH, Dayton PG. Human alpha-1-glycoprotein and its interactions with drugs. Drug Metabolism Reviews 2001; 33: 161–235
   PubMed Web of Science ®Google Scholar
• Lewis EJ, Bishop. J, Aspinall SJ. A simple inflammation model that distinguishes between the actions of anti-inflammatory and anti-rheumatic drugs. Inflammation Research 1998; 47: 26–35
   PubMedGoogle Scholar
• Lin JH, Lu AY. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annual Review of Pharmacology and Toxicology 2001; 41: 535–567
   PubMed Web of Science ®Google Scholar
• Margarson MP, Soni N. Serum albumin: Touchstone or totem?. Anaesthesia 1998; 53: 789–803
   PubMed Web of Science ®Google Scholar
• Morgan ET. Regulation of cytochromes P450 during inflammation and infection. Drug Metabolism Reviews 1997; 29: 1129–1188
   PubMed Web of Science ®Google Scholar
• Negri L, Broccardo M, Lattanzi R, Melchiorri P. Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. British Journal of Pharmacology 1999; 128: 1554–1560
   PubMedGoogle Scholar
• Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Journal of Pharmacology and Experimental Therapeutics 1997; 283: 46–58
   PubMed Web of Science ®Google Scholar
• Oinonen T, Lindros KO. Zonation of hepatic cytochrome P-450 expression and regulation. Biochemical Journal 1998; 329: 17–35
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M, Jamali F. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay. Pharmaceutical Research 1993; 10: 294–299
   PubMed Web of Science ®Google Scholar
• Plobeck N, Delorme D, Wei ZY, Yang H, Zhou F, Schwarz P, Gawell L, Gagnon H, Pelcman B, Schmidt R, et al. New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased in vitro metabolic stability. Journal of Medicinal Chemistry 2000; 43: 3878–3894
   PubMed Web of Science ®Google Scholar
• Projean D, Dautrey S, Vu HK, Groblewski T, Brazier JL, Ducharme J. Selective downregulation of hepatic cytochromes P450 contents and activities in Freund's Complete Adjuvant (FCA)-treated rats. Pharmaceutical Research 2005; 22: 62–70
   PubMedGoogle Scholar
• Schetz JA, Calderon SN, Bertha CM, Rice K, Porreca F. Rapid in vivo metabolism of a methylether derivative of (+/−)-BW373U86: The metabolic fate of [3H]SNC121 in rats. Journal of Pharmacology and Experimental Therapeutics 1996; 279: 1069–1076
   PubMed Web of Science ®Google Scholar
• Shahbazian A, Heinemann A, Schmidhammer H, Beubler B, Holzer-Petsche U, Holzer P. Involvement of mu- and Kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. British Journal of Pharmacology 2002; 135: 741–750
   PubMed Web of Science ®Google Scholar
• Stein C, Millan MJ, Herz A. Unilateral inflammation of the hind paw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds. Pharmacology, Biochemistry, and Behavior 1998; 31: 445–451
   Google Scholar
• Takemoto K, Yamazaki H, Tanaka Y, Nakajima M, Yokoi T. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica 2003; 33: 43–55
   PubMed Web of Science ®Google Scholar
• Wacher VJ, Salphati L, Benet LZ. Active secretion and enterocytic drug metabolism barriers to drug absorption. Advanced Drug Delivery Reviews 2001; 46: 89–102
   PubMed Web of Science ®Google Scholar
• Walker KA, Barber HE, Hawksworth GM. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat. Drug Metabolism and Disposition 1986; 14: 482–486
   PubMed Web of Science ®Google Scholar
• Wei ZY, Brown W, Takasaki B, Plobeck N, Delorme D, Zhou F, Yang H, Jones P, Gawell L, Gagnon H, et al. N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: A novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues. Journal of Medicinal Chemistry 2000; 43: 3895–3905
   PubMedGoogle Scholar
• Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proceedings of the National Academy of Sciences of the USA 1999; 96: 7723–7730
   PubMed Web of Science ®Google Scholar
• Yaksh TL. Spinal systems and pain processing: Development of novel analgesic drugs with mechanistically defined models. Trends in Pharmacological Sciences 1999; 20: 329–337
   PubMed Web of Science ®Google Scholar
• Zhou H. Pharmacokinetic strategies in deciphering atypical drug absorption profiles. Journal of Clinical Pharmacology 2003; 43: 211–227
   PubMed Web of Science ®Google Scholar